drugset / Trial / NCT00662454
Oral Contraceptive Efficacy and Body Weight
Phase 4
Completed
120 enrolled
Oregon Health and Science University
National Institutes of Health (NIH) · collabOregon Clinical and Translational Research Institute · collab
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of the blood spot validation portion of the study is to test if measuring female hormone levels in the blood is as accurate through a finger stick, as it is by a blood draw from a vein. The purpose of the feasibility study is to evaluate ovulation occurrence in two populations of oral contraceptive users: heavier and lighter women.
Timeline
- Start
- 2006-01
- Primary completion
- 2006-05
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Levonorgestrel | Small molecule | 100 ug | Oral |
| Comparator | ethinyl estradiol | Small molecule | 20 ug | Oral |
Indications
No indication recorded.